Walleye Capital LLC Theravance Biopharma, Inc. Transaction History

Walleye Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$8.41 - $10.34 $378,096 - $464,865	44,958 Added 118.94%	82,758 $750,000
Q1 2022 May 16, 2022	BUY	$8.33 - $12.96 $314,874 - $489,888	37,800 New	37,800 $361,000
Q3 2021 Nov 15, 2021	SELL	$6.77 - $14.41 $112,977 - $240,474	-16,688 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$14.52 - $22.46 $242,309 - $374,812	16,688 New	16,688 $242,000

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $640M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.